What information is being gathered about you and how this information is used

Member registration

When you become a registered user of palliativedrugs.com you provide your name, profession, works address, telephone number, e-mail address and unique login name and password. This information is collected on the registration form for several reasons including: (i) personal identification; (ii) to ensure that registered users are health professionals. We reserve the right to independently verify professional details; (iii) to customise the content of our site to meet your specific needs; (iv) to help plan further improvements to the site.
As a member you will also receive a regular e-mail newsletter and all messages posted to the bulletin board. However you may always decline to receive these e-mail messages. Please see Opt out policy below.

E-mail newsletter

The palliativedrugs.com e-mail newsletter is an optional benefit for registered users designed to help inform you of the latest developments relating to the use of drugs in palliative care.

Online surveys

palliativedrugs.com values opinions and comments from its members. There may be occasions when we wish to conduct an online survey. These will be entirely optional for all members. Typically, the information is aggregated and used to make improvements to palliativedrugs.com.

'Cookies'

Cookies are small pieces of information that are stored by your browser on your computer's hard drive. Cookies will be used to track usage of the site. Most web browsers automatically accept cookies, but if you prefer, you can edit your browser options to block them in the future.

Please be aware that we may have links to other web sites that may collect personal identifiable information about you. This privacy statement does not cover the information practice or policies of other such web sites.

Who the information will be shared with, if anyone
We do not sell individual member names or other private profile information to third parties and have no intention of doing so in the future. Anonymous summary data of professionals, their specialities and country of origin may be used for promotional and marketing purposes.

Opt out policy
At any time you can unsubscribe from the email newsletter and/or bulletin board messages.

Access to your information (including how to update or correct inaccuracies)
At any time you can view and update your registration details by selecting 'preferences'.

Safeguards in place to protect your information
Your registration details will be held on a secure server which hosts the site.

Other information about your privacy
palliativedrugs.com contains links to other web sites. Please note that when you click on one of these links you are entering another web site for which palliativedrugs.com has no responsibility. We encourage you to read the privacy statement of all such sites as their policies may be materially different from palliativedrugs.com's privacy statement. Of course, you are solely responsible for maintaining the secrecy of your passwords.
In addition to the circumstances described above, palliativedrugs.com may disclose member information if required to do so by law, court order, as requested by the government or law enforcement authority, or in the good faith belief that disclosure is otherwise necessary or advisable including, without limitation, to protect the rights or properties of palliativedrugs.com or when we have reason to believe that disclosing the information is necessary to identify, contact or bring legal action against someone who may be causing interference with our rights or properties, whether intentionally or otherwise, or when anyone else could be harmed by such activities.
Any material changes in the way palliativedrugs.com uses personal information will be described in future versions of this privacy statement. Of course, you may always submit concerns regarding our privacy statement or our privacy practices to webmaster@palliativedrugs.com. Please reference the privacy policy in your subject line. palliativedrugs.com will attempt to respond to all reasonable concerns or inquiries within five business days of receipt.

Amendments
None as of May 2003